"The Minimally Invasive Urology Institute (MIUI) at The Miriam Hospital is a national leader in robot assisted urologic surgeries. We offer specialized urologic care through a variety of treatment options including minimally invasive laparoscopic and robot-assisted procedures. Minimally invasive procedures use advanced technology to reduce damage to surrounding tissue while performing surgery. The institute’s medical teams provide comprehensive, multidisciplinary care. As appropriate, teams may include urologists, surgeons, internal medicine physicians, nephrologists, oncologists, anesthesiologists, nurses, physical therapists, dietitians, geriatricians, and social workers."

During the past decade, University Urological Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Urological Research Institute" #1 sponsor was "Ferring Pharmaceuticals" with 2 trials, followed by "Abbott" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "GTx" with 1 trials sponsored and "Myrexis Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "University Urological Research Institute" are "Prostate Cancer" (6 trials), "Benign Prostatic Hyperplasia" (1 trials), "Fractures" (1 trials), "Osteoporosis" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "University Urological Research Institute" in a lesser frequency.

Most popular intervention types in "University Urological Research Institute" are "Drug" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Degarelix" (2 trials), "Leuprolide 7.5 mg" (1 trials), "Leuprolide acetate" (1 trials), "Lonidamine" (1 trials) and "MDX-010 / MDX-010 + Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Urological Research Institute" are 8 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Urological Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Urological Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Urological Research Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".